The following stories appear in full on today's Vidyya Medical News Service Web site.
The Agency for Healthcare Research and Quality (AHRQ) this week announced funding for a major new research initiative that will improve knowledge of the factors underlying ethnic and racial inequities in health care, the EXCEED (Excellence Centers to Eliminate Ethnic/Racial Disparities) initiative. The studies also will help identify practical tools and strategies to eliminate these disparities.
Americans who get hands-on help from others so that they can accomplish life's basic daily activities are not necessarily elderly nor do they all live in nursing homes, according to a new report by the Agency for Healthcare Research and Quality (AHRQ). The report may ultimately change the way in home healthcare is funded by the government and insurance companies.
The flu season is upon us. If your patients have a family member who has already been diagnosed with the flu, they may ask you about a prescription for zanamivir. According to findings in last week's New England Journal of Medicine, zanamivir, an inhaled drug, could keep the virus at bay for the rest of the patient's household. Though the drug is approved only for the relief of flu symptoms, given the new research, we thought you might be interested in reviewing the prescribing information.
Influenza viruses are divided into three types, designated A, B,
and C. Influenza types A and B are responsible for epidemics that occur almost every winter, and are associated with increased rates for hospitalization and death. Epidemics of influenza occur during the winter months nearly every year and are responsible for an average of approximately 20,000 deaths per year in the United States. There are currently several antiviral medications on the market that may help control flu and other viral-mediated diseases. Read more information about them in today's issue.
As always, we hope you enjoy the issue.